Daniel Bock

688 total citations
17 papers, 486 citations indexed

About

Daniel Bock is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel Bock has authored 17 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel Bock's work include Complement system in diseases (5 papers), Receptor Mechanisms and Signaling (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Daniel Bock is often cited by papers focused on Complement system in diseases (5 papers), Receptor Mechanisms and Signaling (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Daniel Bock collaborates with scholars based in Germany, United States and United Kingdom. Daniel Bock's co-authors include Jörg Köhl, Andreas Klos, Ulrich Martin, Wilfried Bautsch, Robert S. Ames, Lubomir Arseniev, Arnold Ganser, Mark Tornetta, G. Wolff and Claudia Rheinheimer and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Daniel Bock

17 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Bock Germany 12 294 148 95 64 54 17 486
James L. Mobley United States 12 246 0.8× 152 1.0× 124 1.3× 46 0.7× 83 1.5× 18 504
Mads Krogsgaard Thomsen Denmark 15 201 0.7× 126 0.9× 62 0.7× 68 1.1× 79 1.5× 28 552
Asuka Inoue Japan 17 331 1.1× 169 1.1× 83 0.9× 42 0.7× 147 2.7× 41 691
Viviane Tricottet France 10 197 0.7× 167 1.1× 28 0.3× 52 0.8× 55 1.0× 17 575
Shinji Kagaya Japan 9 148 0.5× 227 1.5× 55 0.6× 38 0.6× 67 1.2× 14 544
A. Wölpl Germany 9 345 1.2× 168 1.1× 52 0.5× 44 0.7× 82 1.5× 31 616
Christina Stoeckle Switzerland 15 396 1.3× 222 1.5× 53 0.6× 129 2.0× 86 1.6× 21 762
Caitlin M. Gillis France 11 334 1.1× 219 1.5× 101 1.1× 75 1.2× 32 0.6× 15 631
Jason Douangpanya United States 5 437 1.5× 357 2.4× 46 0.5× 93 1.5× 131 2.4× 5 784
Karin Kissel Germany 11 249 0.8× 120 0.8× 62 0.7× 75 1.2× 55 1.0× 16 578

Countries citing papers authored by Daniel Bock

Since Specialization
Citations

This map shows the geographic impact of Daniel Bock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bock more than expected).

Fields of papers citing papers by Daniel Bock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bock. The network helps show where Daniel Bock may publish in the future.

Co-authorship network of co-authors of Daniel Bock

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bock. A scholar is included among the top collaborators of Daniel Bock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bock. Daniel Bock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bock, Daniel, Jochen Senges, Matthias Hochadel, et al.. (2018). The German CPU registry: Comparison of smokers and nonsmokers. Herz. 45(3). 293–298. 3 indexed citations
2.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2012). Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD. Pulmonary Pharmacology & Therapeutics. 26(2). 265–270. 42 indexed citations
3.
Watz, Henrik, Daniel Bock, Michael C. Meyer, et al.. (2011). Late-breaking abstract: Inhaled pan-selectin antagonist bimosiamose in COPD: A double-blind, randomized, placebo-controlled phase II study. European Respiratory Journal. 38(Suppl 55). 4492–4492. 2 indexed citations
4.
Kirsten, Anne, Henrik Watz, Gunther Kretschmar, et al.. (2011). Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial. Pulmonary Pharmacology & Therapeutics. 24(5). 555–558. 24 indexed citations
5.
Kranich, Remo, Daniel Bock, Diana Beyer, et al.. (2007). Rational Design of Novel, Potent Small Molecule Pan-Selectin Antagonists. Journal of Medicinal Chemistry. 50(6). 1101–1115. 35 indexed citations
6.
Bock, Daniel, Sandra Philipp, & G. Wolff. (2006). Therapeutic potential of selectin antagonists in psoriasis. Expert Opinion on Investigational Drugs. 15(8). 963–979. 13 indexed citations
7.
Bock, Daniel, et al.. (2006). The Role of Selectins During Lung Inflammation and Their Potential Impact for Innovative Therapeutic Strategies. Current Respiratory Medicine Reviews. 2(3). 339–354. 5 indexed citations
8.
Friedrich, Markus, Daniel Bock, Sandra Philipp, et al.. (2005). Pan-selectin antagonism improves psoriasis manifestation in mice and man. Archives of Dermatological Research. 297(8). 345–351. 51 indexed citations
9.
Rheinheimer, Claudia, Robert S. Ames, Alan Wise, et al.. (2003). Structure‐function studies of the C3a‐receptor: C‐terminal serine and threonine residues which influence receptor internalization and signaling. European Journal of Immunology. 33(4). 920–927. 22 indexed citations
10.
Grotz, M., Hans‐Christoph Pape, Martijn van Griensven, et al.. (2001). GLYCINE REDUCES THE INFLAMMATORY RESPONSE AND ORGAN DAMAGE IN A TWO-HIT SEPSIS MODEL IN RATS. Shock. 16(2). 116–121. 29 indexed citations
11.
Balish, Edward, T. Warner, C Pierson, Daniel Bock, & R. Doug Wagner. (2001). Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Medical Mycology. 39(3). 261–268. 32 indexed citations
12.
Bock, Daniel, et al.. (1999). Modulation of C3a Activity: Internalization of the Human C3a Receptor and its Inhibition by C5a. The Journal of Immunology. 162(12). 7409–7416. 27 indexed citations
13.
Martin, Ulrich, Daniel Bock, Lubomir Arseniev, et al.. (1997). The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes. The Journal of Experimental Medicine. 186(2). 199–207. 141 indexed citations
14.
Bock, Daniel, Ulrich Martin, Claudia Rheinheimer, et al.. (1997). The C terminus of the human C5a receptor (CD88) is required for normal ligand‐dependent receptor internalization. European Journal of Immunology. 27(6). 1522–1529. 28 indexed citations
15.
Martin, Ulrich, Daniel Bock, Lubomir Arseniev, et al.. (1997). The human C3a receptor is expressed on neutrophils and monocytes but not on B- or T-lymphocytes. Immunology Letters. 56. 114–114. 2 indexed citations
16.
Burg, Michael, Ulrich Martin, Daniel Bock, et al.. (1996). Differential regulation of the C3a and C5a receptors (CD88) by IFN-γ and PMA in U937 cells and related myeloblastic cell lines. The Journal of Immunology. 157(12). 5574–5581. 29 indexed citations
17.
Bock, Daniel, et al.. (1982). [An unforeseen incident in the use of a type A overhead-anesthesia system in an operating room].. PubMed. 31(9). 466–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026